Unique ID issued by UMIN | UMIN000046566 |
---|---|
Receipt number | R000053106 |
Scientific Title | A Study on the Effect of Test Food on Joint Function -A Randomized, Double-blind, Placebo-controlled, Parallel-group Study- |
Date of disclosure of the study information | 2022/01/07 |
Last modified on | 2022/01/05 14:33:32 |
A Study on the Effect of Test Food on Joint Function
-A Randomized, Double-blind, Placebo-controlled, Parallel-group Study-
A Study on the Effect of Test Food on Joint Function
A Study on the Effect of Test Food on Joint Function
-A Randomized, Double-blind, Placebo-controlled, Parallel-group Study-
A Study on the Effect of Test Food on Joint Function
Japan |
No
Adult |
Others
NO
To confirm the effect of test food on joint function
Efficacy
assessment of joint function
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Treatment
Food |
Active food,
12 weeks consumption
Placebo food,
12 weeks consumption
40 | years-old | <= |
75 | years-old | > |
Male and Female
1)Males and females aged 40 to 74 years-old with discomfort of joints.
2)Subjects whose knee joints are judged to be not diseased by the investigator according to the Kellgren-Lawrence grade (KL grade) in X-ray at screening tests.
3)Subjects whose BMI are less than 30.
4)Subjects who can make self-judgment and are voluntarily giving written informed consent.
Subjects (who)
1)have a history of and/or contract rheumatoid arthritis, or are suspected to have rheumatoid arthritis by screening tests.
2)underwent surgery for chronic pain in joints, ligament injury or meniscus injury.
3)with artificial joints, etc.
4)take joint related medicines (such as poultices, liniments, and/or analgesics, etc.) three or more times a week.
5)have a history of and/or contract serious diseases (eg, liver disease, kidney disease, digestive disease, heart disease, respiratory disease, endocrine disease, metabolic disease and/or joint disease).
6)can't stop using drugs and/or supplements affecting joints during the study period.
7)have allergy to ingredients of test foods.
8)are pregnant or planning to become pregnant or breastfeed during the study period.
9)have donated over 200 mL of blood and/or blood components within the last one month prior to the current study or over 400 mL of blood and/or blood components within the last three months prior to screening tests.
10)had participated in other clinical studies within the last one month prior to the current study and/or are planning to participate in other clinical studies during the current study.
11)are judged as unsuitable for the current study by the investigator for other reasons.
60
1st name | Naoya |
Middle name | |
Last name | Sekiguchi |
Urayasu Sekiguchi Clinic
Director
279-0004
5-17-27 Nekozane, Urayasu-shi, Chiba
047-306-3557
scfira@royal.ocn.ne.jp
1st name | Yoshika |
Middle name | |
Last name | Komori |
KSO Corporation
Sales department
105-0023
1-9-7 Shibaura, Minato-ku, Tokyo
03-3452-7733
eigyou27@kso.co.jp
KSO Corporation
TOYO SHINYAKU Co., Ltd.
Profit organization
Ethical Committee of Nihonbashi Cardiology Clinic
Kyodo Bldg. #201, 13 - 4 Nihonbashi Kodenmacho, Chuo-ku, Tokyo
03-5641-4133
niho-jimucho@well-sleep.jp
NO
2022 | Year | 01 | Month | 07 | Day |
Unpublished
Preinitiation
2021 | Year | 12 | Month | 21 | Day |
2022 | Year | 01 | Month | 09 | Day |
2022 | Year | 06 | Month | 30 | Day |
2022 | Year | 01 | Month | 06 | Day |
2022 | Year | 01 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053106